The information was revealed
by Engineer Alberto Agraz, General Director of the center
who highlighted among some of their most important
achievements the quality management system for over one
decade, nationally and internationally endorsed,
constituting a guarantee for the populationís health.
The center also packages and
delivers different bio-pharmaceutical products for
commercialization, among them the anti hepatitis recombinant
vaccine and the Alfa interferon.
Also among top on the list is
a vaccine used in preventing Haemophilus influenza and the
Heberprot-P against foot ulcers on people with diabetes.
Other important sectors of
BIOCEN are the development of a tonic of natural origin for
the treatment of anemia and the elaboration of nutrient
bases for the diagnosis of microbiological analysis
including a group of the chromogenic and Fluorgeneic types,
faster and more precise in their results.
There is also the fabrication
of active ingredients for the production of different
medications in addition to extracts that produce allergies
for its diagnosis and treatment applicable under the tongue
or injected on the upper layer of the skin.
With over one thousand
workers, BIOCEN, in the province of Mayabeque has a number
of installations, among them a new center.